POLG expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.146000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.802000E-01
Normal-vs-Stage2
3.949600E-01
Normal-vs-Stage3
1.860780E-01
Normal-vs-Stage4
3.071400E-01
Stage1-vs-Stage2
6.003500E-02
Stage1-vs-Stage3
5.237400E-01
Stage1-vs-Stage4
7.428400E-01
Stage2-vs-Stage3
1.860390E-01
Stage2-vs-Stage4
7.198400E-01
Stage3-vs-Stage4
4.650200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.441000E-01
Normal-vs-AfricanAmerican
1.537440E-01
Normal-vs-Asian
3.087400E-01
Caucasian-vs-AfricanAmerican
5.431400E-01
Caucasian-vs-Asian
4.992200E-01
AfricanAmerican-vs-Asian
9.414200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.121400E-01
Normal-vs-Female
1.896590E-01
Male-vs-Female
5.410000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.032600E-01
Normal-vs-Age(41-60Yrs)
3.656400E-01
Normal-vs-Age(61-80Yrs)
2.675600E-01
Normal-vs-Age(81-100Yrs)
5.697600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.028000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.700000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.582200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.129550E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.161800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.834600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.704400E-01
Normal-vs-Daily Drinker
1.888570E-01
Normal-vs-Weekly Drinker
2.803800E-01
Normal-vs-Occasional Drinker
2.081200E-01
Normal-vs-Social Drinker
3.728600E-01
Non Drinker-vs-Daily Drinker
2.868000E-01
Non Drinker-vs-Weekly Drinker
6.656400E-01
Non Drinker-vs-Occasional Drinker
5.721400E-01
Non Drinker-vs-Social Drinker
9.937600E-01
Daily Drinker-vs-Weekly Drinker
5.948400E-01
Daily Drinker-vs-Occasional Drinker
6.037400E-01
Daily Drinker-vs-Social Drinker
2.993400E-01
Weekly Drinker-vs-Occasional Drinker
9.382000E-01
Weekly Drinker-vs-Social Drinker
6.394200E-01
Occasional Drinker-vs-Social Drinker
5.432000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.524000E-01
Normal-vs-Grade 2
8.477800E-01
Normal-vs-Grade 3
7.799600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.151030E-01
Grade 1-vs-Grade 3
1.465510E-02
Grade 1-vs-Grade 4
9.524000E-01
Grade 2-vs-Grade 3
1.250960E-01
Grade 2-vs-Grade 4
8.477800E-01
Grade 3-vs-Grade 4
7.799600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.156200E-01
Normal-vs-NonDiabetic
3.215600E-01
Diabetic-vs-NonDiabetic
3.167000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.368600E-01
Normal-vs-NoPancreatitis
2.740800E-01
Pancreatitis-vs-NoPancreatitis
4.657700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.643640E-01
Normal-vs-N1
4.169000E-01
N0-vs-N1
1.628220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.598800E-01
Normal-vs-TP53-NonMutant
2.688200E-01
TP53-Mutant-vs-TP53-NonMutant
5.026100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
